Oral Obesity Therapies market to reach $6.32 billion by 2030 at 9.9% CAGR, driven by increasing obesity prevalence, oral GLP-1 adoption, and personalized metabolic treatments.
Oral Microbiome Products market to reach $2.08 billion by 2030 at 14.5% CAGR, driven by rising dental diseases, aging populations, and demand for personalized oral care.
The Mepolizumab market size is expected to reach $3.21 billion by 2030 at a CAGR of 7.7%, driven by increasing global burden of asthma.
The Magnetic Resonance Imaging (MRI) Contrast Agents market size is expected to reach $2.17 billion by 2030 at a CAGR of 7.4%, driven by rising prevalence of chronic diseases.
Test Message
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.